Wooree Bio Co.Ltd (082850) — Capital Reinvestment Ratio
Latest as of March 2026:
0.09x
Wooree Bio Co.Ltd (082850) has a Capital Reinvestment Ratio of 0.09x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩33.98 Billion) in capital expenditures (₩3.07 Billion). See how much free cash does Wooree Bio Co.Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.09x
Capex / Operating Cash Flow
Operating Cash Flow
₩33.98 Billion
KRW
Capital Expenditures
₩3.07 Billion
KRW
Data as of
Mar 2026
Most recent filing
Wooree Bio Co.Ltd Capital Reinvestment Ratio (2008–2025)
This chart tracks Wooree Bio Co.Ltd's Capital Reinvestment Ratio across 15 annual periods.
Annual Capital Reinvestment Ratio for Wooree Bio Co.Ltd (2008–2025)
Year-by-year Capital Reinvestment Ratio for Wooree Bio Co.Ltd from 2008 to 2025. For live market cap and broader valuation context, see how much is Wooree Bio Co.Ltd worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.64x | ₩34.82 Billion | ₩22.42 Billion | ▼ -72.1% |
| 2024 | 2.31x | ₩36.24 Billion | ₩83.57 Billion | ▲ +452.5% |
| 2023 | 0.42x | ₩26.51 Billion | ₩11.07 Billion | ▲ +34.8% |
| 2022 | 0.31x | ₩43.35 Billion | ₩13.42 Billion | ▲ +33.8% |
| 2021 | 0.23x | ₩50.21 Billion | ₩11.62 Billion | ▼ -6.9% |
| 2020 | 0.25x | ₩69.43 Billion | ₩17.26 Billion | ▼ -32.2% |
| 2019 | 0.37x | ₩65.80 Billion | ₩24.11 Billion | ▼ -85.9% |
| 2018 | 2.59x | ₩10.82 Billion | ₩28.04 Billion | ▲ +115.2% |
| 2017 | 1.20x | ₩27.73 Billion | ₩33.37 Billion | ▲ +16.1% |
| 2014 | 1.04x | ₩54.31 Billion | ₩56.29 Billion | ▼ -18.2% |
| 2013 | 1.27x | ₩80.75 Billion | ₩102.35 Billion | ▼ -75.3% |
| 2011 | 5.12x | ₩8.36 Billion | ₩42.84 Billion | ▲ +9.2% |
| 2010 | 4.69x | ₩17.33 Billion | ₩81.28 Billion | ▲ +666.2% |
| 2009 | 0.61x | ₩46.60 Billion | ₩28.53 Billion | ▲ +5.1% |
| 2008 | 0.58x | ₩69.27 Billion | ₩40.36 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow